| Literature DB >> 23055841 |
Maria L Salazar1, Lea S Eiland.
Abstract
Childhood obesity is increasing in prevalence in the United States. Comorbid diseases once thought of as adult issues such as hypertension, diabetes, and dyslipidemia, are now being encountered in the pediatric population as a result of obesity. Primary prevention is still the most cost-effective approach to this growing problem. In terms of management, the treatment of obesity in children is not identical to that in adults. Thus far, the only accepted weight loss therapy for children are diet, exercise, modification of eating behaviors and family education. Further options for morbidly obese children include weight loss medications or surgery, regarding which long-term benefits are still under investigation.Entities:
Keywords: adolescent; anti-obesity agents; body weight; child; diet therapy; obesity; orlistat; pediatrics; sibutramine
Year: 2007 PMID: 23055841 PMCID: PMC3462158 DOI: 10.5863/1551-6776-12.1.23
Source DB: PubMed Journal: J Pediatr Pharmacol Ther ISSN: 1551-6776